Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Baseline characteristics of the subjects

From: Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]

 

N-Acetylcysteine (n = 25)

Placebo (n = 25)

Gender Male/Female

11/14

19/6

Age Years (SD)

73.6 (7.8)

73.0 (8.2)

Smoking History Pack Years (SD)

44.4 (36.2)

53.7 (36.8)

FEV 1 % predicted (SD)

22 (10)

24 (12)

VC % predicted (SD)

56 (18)

64 (22)

SaO 2 % (SD)

90.2 (4.0)

90.4 (2.7)

Breathlessness Likert Score (IQ range)

4 (3–6)

4 (3–5)

  1. Values are shown as mean and standard deviation except for Likert scores that are shown as median and interquartile range. There were no statistically significant differences between the two groups for any of the measures.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us